Ceftazidime
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Pharmaceuticals
Kyongbo Pharmaceutical Co., Ltd.
- Country / Year Established
-
South Korea
/
- Business type
- Others
- Verified Certificate
-
16
| Product name | Ceftazidime | Certification | - |
|---|---|---|---|
| Category | Pharmaceuticals | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
CAS No. : [78439-06-2]
Formula: C22H22N6O7S2 . 5H2O
Mol. Weight: 636.67
Conformed to: USP, EP, BP, JP, KP
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Kang, Tae Won
- Address
- 174 Silok-ro, Asan-Si, Chungcheongnam-Do, 336-020, Korea
- Product Category
- Other Pharmaceutical Chemicals
- No. of Total Employees
- 101-500
- Company introduction
-
ISO 9001(QMS) / 14001(EMS), GMP Certification
Kyongbo Pharmaceuical Co., Ltd. is a subsidiary company of Chong Kun Dang pharmaceutical corp. The company is a pioneer in the active pharmaceutical industry in Korea, founded in 1987, with a future-oriented outlook for fine chemistry as a promising high-tech industry for the 21st century and with the humanitarian mission to contribute to the life and health of mankind.
With its primary goal set in developing new pharmaceutical substances, the company operates under the main strategy the secure superior competitive edge by simplifying and streamlining its manufacturing procedures through technological innovation and producing highly profitable raw materials for drugs.
- Main Markets
-
China
Italy
Japan
South Korea
- Main Product
_2.jpg "Sentrip Oral Dissolving Film 10mg_20mg_Treatment for Erectile dysfunction__1")
